193 related articles for article (PubMed ID: 12938734)
1. Interactions between environmental and genetic factors in the pathophysiology of Parkinson's disease.
Tsang F; Soong TW
IUBMB Life; 2003 Jun; 55(6):323-7. PubMed ID: 12938734
[TBL] [Abstract][Full Text] [Related]
2. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
[TBL] [Abstract][Full Text] [Related]
3. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
[TBL] [Abstract][Full Text] [Related]
4. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
6. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
7. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease.
Przedborski S; Vila M
Ann N Y Acad Sci; 2003 Jun; 991():189-98. PubMed ID: 12846987
[TBL] [Abstract][Full Text] [Related]
8. Gene-environment interactions in Parkinson's disease.
Ross CA; Smith WW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S309-15. PubMed ID: 18267256
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Parkinson's disease.
Schapira AH
Baillieres Clin Neurol; 1997 Apr; 6(1):15-36. PubMed ID: 9426866
[TBL] [Abstract][Full Text] [Related]
10. Models of Parkinson's disease.
Orth M; Tabrizi SJ
Mov Disord; 2003 Jul; 18(7):729-37. PubMed ID: 12815651
[TBL] [Abstract][Full Text] [Related]
11. Genetic contributions to Parkinson's disease.
Huang Y; Cheung L; Rowe D; Halliday G
Brain Res Brain Res Rev; 2004 Aug; 46(1):44-70. PubMed ID: 15297154
[TBL] [Abstract][Full Text] [Related]
12. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
[TBL] [Abstract][Full Text] [Related]
13. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and reactive oxygen species in Parkinson's disease.
Tieu K; Ischiropoulos H; Przedborski S
IUBMB Life; 2003 Jun; 55(6):329-35. PubMed ID: 12938735
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
17. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
Faherty CJ; Raviie Shepherd K; Herasimtschuk A; Smeyne RJ
Brain Res Mol Brain Res; 2005 Mar; 134(1):170-9. PubMed ID: 15790541
[TBL] [Abstract][Full Text] [Related]
18. Experimental models of Parkinson's disease: insights from many models.
Tolwani RJ; Jakowec MW; Petzinger GM; Green S; Waggie K
Lab Anim Sci; 1999 Aug; 49(4):363-71. PubMed ID: 10480640
[TBL] [Abstract][Full Text] [Related]
19. Gene-environment interactions in Parkinson's disease and other forms of parkinsonism.
Vance JM; Ali S; Bradley WG; Singer C; Di Monte DA
Neurotoxicology; 2010 Sep; 31(5):598-602. PubMed ID: 20430055
[TBL] [Abstract][Full Text] [Related]
20. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice.
Sakai R; Irie Y; Murata T; Ishige A; Anjiki N; Watanabe K
Phytother Res; 2007 Sep; 21(9):868-73. PubMed ID: 17486689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
